Abuderman Abdulwahab A, Harb Ola A, Gertallah Loay M
Department of Basic Medical Sciences, College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Department of Pathology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Contemp Oncol (Pozn). 2020;24(3):183-192. doi: 10.5114/wo.2020.100281. Epub 2020 Oct 30.
HOXB8 is a protein that was found to promote cancer proliferation and invasion. ILK is a protein kinase which has a role in carcinogenesis. FAT4 is a tumor homologue that has a role in EMT and autophagy regulation.
To identify expression of Human HOXB8, Integrin-linked kinase (ILK1) and FAT homolog 4 (FAT4) in colorectal cancer (CRC) correlating their expression with pathological, prognostic and clinical parameters of CRC.
We assessed the expression of HOXB8, ILK and FAT4 in fifty CRC patients and ten samples from nearby non-neoplastic colonic mucosa using immunohistochemistry.
The expression of HOXB8 and ILK in CRC was positively associated with high tumor grade, advanced tumor stage, lymph node involvement ( < 0.001), occurrence of distant metastases ( = 0.003 and 0.024 respectively), higher incidence of tumor recurrence ( = 0.03, < 0.001 respectively), worse survival rates ( = 0.038 and 0.003 respectively). The expression of FAT4 in CRC was correlated with lower grade, early stage of the tumor, absence of lymph node involvement ( < 0.001) and lack of distant metastases ( = 0.011). High FAT4 expression was associated with absence of tumor recurrence ( < 0.001) and favorable survival rates ( < 0.001 and 0.003).
High immunohistochemical expression of HOXB8 and ILK in addition to low immunohistochemical expression of FAT4 was associated with unfavorable prognostic and pathological parameters of CRC.
HOXB8是一种被发现可促进癌症增殖和侵袭的蛋白质。整合素连接激酶(ILK)是一种在致癌过程中起作用的蛋白激酶。FAT4是一种肿瘤同源物,在上皮-间质转化(EMT)和自噬调节中起作用。
确定人HOXB8、整合素连接激酶(ILK1)和FAT同源物4(FAT4)在结直肠癌(CRC)中的表达,并将它们的表达与CRC的病理、预后和临床参数相关联。
我们使用免疫组织化学方法评估了50例CRC患者以及10份来自附近非肿瘤性结肠黏膜样本中HOXB8、ILK和FAT4的表达。
CRC中HOXB8和ILK的表达与高肿瘤分级、肿瘤晚期、淋巴结受累(<0.001)、远处转移的发生(分别为=0.003和0.024)、肿瘤复发的较高发生率(分别为=0.03,<0.001)、较差的生存率(分别为=0.038和0.003)呈正相关。CRC中FAT4的表达与较低分级、肿瘤早期、无淋巴结受累(<0.001)和无远处转移(=0.011)相关。高FAT-4表达与无肿瘤复发(<0.001)和良好的生存率(<0.001和0.003)相关。
HOXB8和ILK的高免疫组化表达以及FAT4的低免疫组化表达与CRC不良的预后和病理参数相关。